Human trials start this week on an ebola vaccine developed by local pharmaceutical giant GlaxoSmithKline.
“This has been a rough year,” said Nora Solo at a church service in South Philadelphia. “The children died in the fire, and then Ebola is going on.”
Dr. Ronald Harty and his team are studying the molecular workings of viruses, aiming to reduce their ability to spread infection.
The recent outbreak of the Ebola virus in Africa has begun attracting attention in the U.S. for good reason.
The Ebola outbreak in West Africa is the largest ever, but the risk of it spreading to the United States is very low.